Afecta Pharmaceuticals is a patient-centric pharmaceutical company with a focus on developing precision medicines for complex diseases and cancers. The company's proprietary Artificial Intelligence-powered disease/drug targeting platform, PharmetRx™, has been validated through the discovery and optimization of "Smart Drugs" that target multiple pathways related to the disease process. These drugs are then formulated using NanoRx, the company's Tissue Specific Drug Delivery technology. Afecta's current internal drug development programs concentrate on addressing unmet needs in chronic diseases and cancers. The company's slogan, "Creating Precision Medicines...More Efficiently," reflects its commitment to harnessing innovative technologies to advance drug development and enhance treatment efficacy. Afecta Pharmaceuticals operates within the Health Care, Health and Wellness, and Pharmaceutical industries.
There is no investment information
No recent news or press coverage available for Afecta Pharmaceuticals.